Capital Analysts LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,057
| Closed | -$84K | – | 1138 |
|
|
2022
Q2 | $84K | Buy |
1,057
+271
| +34% | +$21.5K | 0.01% | 457 |
|
|
2022
Q1 | $83K | Hold |
786
| – | – | 0.01% | 464 |
|
|
2021
Q4 | $85K | Hold |
786
| – | – | 0.01% | 478 |
|
|
2021
Q3 | $86K | Buy |
786
+212
| +37% | +$23.2K | 0.01% | 485 |
|
|
2021
Q2 | $54K | Buy |
+574
| New | +$54K | ﹤0.01% | 550 |
|
|
2020
Q4 | – | Sell |
-19,550
| Closed | -$1.52M | – | 838 |
|
|
2020
Q3 | $1.52M | Buy |
19,550
+4,650
| +31% | +$361K | 0.14% | 126 |
|
|
2020
Q2 | $828K | Buy |
14,900
+7,900
| +113% | +$439K | 0.09% | 161 |
|
|
2020
Q1 | $207K | Sell |
7,000
-3,250
| -32% | -$96.1K | 0.03% | 205 |
|
|
2019
Q4 | $371K | Buy |
10,250
+4,750
| +86% | +$172K | 0.04% | 197 |
|
|
2019
Q3 | $149K | Buy |
+5,500
| New | +$149K | 0.02% | 243 |
|